Literature DB >> 5575551

Control of secondary hyperparathyroidism during long-term hemodialysis.

R S Goldsmith, J Furszyfer, W J Johnson, A E Fournier, C D Arnaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5575551     DOI： 10.1016/0002-9343(71)90125-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  11 in total

1.  Dailysate calcium and plasma calcium fractions during and after haemodialysis.

Authors:  C Fuchs; M Brasche; U Donath-Wolfram; J Kubosch; E Quellhorst; F Scheler
Journal:  Klin Wochenschr       Date:  1975-01

2.  The effect of dialysate magnesium concentration on serum PTH-levels in patients on maintenance haemodialysis.

Authors:  E Ritz; V Lenhard; J Bommer; W Hackeng
Journal:  Klin Wochenschr       Date:  1974-01-01

3.  Antacid induction of phosphate depletion syndrome in renal failure.

Authors:  D E Abrams; R B Silcott; R Terry; T V Berne; B H Barbour
Journal:  West J Med       Date:  1974-02

4.  Metastatic calcification and dialysis.

Authors: 
Journal:  Br Med J       Date:  1972-03-25

5.  Osteopathy in maintenance hemodialysis.

Authors:  B Krempien; E Ritz; U Beck; H Keilbach
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

6.  Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.

Authors:  R J Winney; J M Bone; T J Anderson; J S Robson
Journal:  Calcif Tissue Res       Date:  1977-05

7.  Calcium uptake and phosphate removal during hemodialysis with variing dialysate calcium.

Authors:  F Skrabal; P Dittrich; F Gabl
Journal:  Klin Wochenschr       Date:  1974-05-15

8.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.

Authors:  D E Memmos; J B Eastwood; L B Talner; P E Gower; J R Curtis; M E Phillips; G D Carter; J Alaghband-Zadeh; A P Roberts; H E de Wardener
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

Review 10.  Renal bone disease.

Authors:  G R Catto
Journal:  J R Coll Physicians Lond       Date:  1976-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.